These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


230 related items for PubMed ID: 14535878

  • 41. Effect of incorporating a thiophene tail in the scaffold of acetazolamide on the inhibition of human carbonic anhydrase isoforms I, II, IX and XII.
    Biswas S, McKenna R, Supuran CT.
    Bioorg Med Chem Lett; 2013 Oct 15; 23(20):5646-9. PubMed ID: 23993330
    [Abstract] [Full Text] [Related]

  • 42. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
    Thiry A, Dogné JM, Masereel B, Supuran CT.
    Trends Pharmacol Sci; 2006 Nov 15; 27(11):566-73. PubMed ID: 16996620
    [Abstract] [Full Text] [Related]

  • 43. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
    Swinson DE, Jones JL, Richardson D, Wykoff C, Turley H, Pastorek J, Taub N, Harris AL, O'Byrne KJ.
    J Clin Oncol; 2003 Feb 01; 21(3):473-82. PubMed ID: 12560438
    [Abstract] [Full Text] [Related]

  • 44. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3102-8. PubMed ID: 15905091
    [Abstract] [Full Text] [Related]

  • 45. Discovering novel carbonic anhydrase type IX (CA IX) inhibitors from seven million compounds using virtual screening and in vitro analysis.
    Salmas RE, Senturk M, Yurtsever M, Durdagi S.
    J Enzyme Inhib Med Chem; 2016 Jun 15; 31(3):425-33. PubMed ID: 25950196
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Expression and activity of carbonic anhydrase IX is associated with metabolic dysfunction in MDA-MB-231 breast cancer cells.
    Li Y, Wang H, Oosterwijk E, Tu C, Shiverick KT, Silverman DN, Frost SC.
    Cancer Invest; 2009 Jul 15; 27(6):613-23. PubMed ID: 19367501
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors.
    Rosatelli E, Carotti A, Ceruso M, Supuran CT, Gioiello A.
    Bioorg Med Chem Lett; 2014 Aug 01; 24(15):3422-5. PubMed ID: 24948563
    [Abstract] [Full Text] [Related]

  • 54. Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII.
    Esirden İ, Ulus R, Aday B, Tanç M, Supuran CT, Kaya M.
    Bioorg Med Chem; 2015 Oct 15; 23(20):6573-80. PubMed ID: 26422787
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX.
    Murri-Plesko MT, Hulikova A, Oosterwijk E, Scott AM, Zortea A, Harris AL, Ritter G, Old L, Bauer S, Swietach P, Renner C.
    Eur J Pharmacol; 2011 Apr 25; 657(1-3):173-83. PubMed ID: 21315712
    [Abstract] [Full Text] [Related]

  • 57. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
    Huang WJ, Jeng YM, Lai HS, Fong IU, Sheu FY, Lai PL, Yuan RH.
    PLoS One; 2015 Apr 25; 10(3):e0119181. PubMed ID: 25738958
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates.
    Winum JY, Pastorekova S, Jakubickova L, Montero JL, Scozzafava A, Pastorek J, Vullo D, Innocenti A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Feb 01; 15(3):579-84. PubMed ID: 15664816
    [Abstract] [Full Text] [Related]

  • 60. Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours.
    Kivelä AJ, Parkkila S, Saarnio J, Karttunen TJ, Kivelä J, Parkkila AK, Pastoreková S, Pastorek J, Waheed A, Sly WS, Rajaniemi H.
    Histochem Cell Biol; 2000 Sep 01; 114(3):197-204. PubMed ID: 11083462
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.